Drug – Page 2 – Beautifaire

29 Jul

The drug, which promotes fast muscle growth, is actually steroids in pill form – but how protected is it really? If you happen to spend time on the fitspo side of the web, it’s likely you’ll have heard of SARMs. SARMs – short for selective androgen receptor modulators – are a sort of image or performance-enhancing drug (IPED) that promote fast muscle growth. The largest difference between SARMs and steroids is that, while steroids should be injected, SARMs are taken as a pill, like a complement. A recent BBC News investigation found that SARMs, that are unregulated, are being sold illegally in shops across the UK, but they’re also available to buy online. Research...

0 Comments

26 Jun

Ozempic: a pill type of the divisive weight-loss drug

by Beauty Tips

Beauty, Featured

Pharmaceutical corporations are racing to be the primary to bring an oral version of semaglutide to the market and it could come throughout the next yr A pill type of Ozempic is on its way as drugmakers reportedly race to grow to be the primary comapny to bring an oral version of the diabetes and weight-loss drug to the market. Until now, semaglutide – sold under branded names including Ozempic, Wegovy and Mounjaro – has been predominantly available as an injection, but data from several latest studies suggests that a latest pill might be just as effective in reducing weight and blood sugar for people each with and without diabetes. Pharmaceutical corporations Eli...

0 Comments

16 Jun

This Drug Could Slow Down Ovary Aging and Delay

by Beautifaire101

Beauty, Featured

Rapamycin, a drug currently undergoing clinical studies at Columbia University, could delay ovary aging and, in turn, delay menopause, while also reducing future symptom severity. The Columbia clinical study marks the primary time the drug has been tested on humans, because it has previously been tested on animals at several clinics, which showed that it could extend lifespan and slow aging. The trial, led by Dr. Zev Williams, chief of the division of reproductive endocrinology and infertility at Columbia University Fertility Center, and Dr. Yousin Suh, director of the reproductive aging program at Columbia, is a randomized, double-blind, placebo-controlled study taking a look at the consequences of weekly low dose rapamycin on women ages 35 to 42 over the course of three...

0 Comments

30 Apr